Consulting Regulatory affairs input and Guidance on
Consulting
Regulatory Strategy To define a coherent regulatory strategy is not just a matter !
Regulatory Strategy
Biotech Products Recombinant DNA proteins - Vaccines - CELL THERAPY
Biotech Products
Interactions with Regulatory Bodies RLM Consulting has direct contacts with most EU national agencies and the EMA
Interactions with Regulatory Bodies
Submissions Clinical Trial Applications (CTA) - Marketing Authorisation Applications (MAA)
Submissions
Due Diligence For the assessment of an investment project - For a client considering licensing in a novel product
Due Diligence
Good Research and Laboratory Practice Small and Medium size Enterprises (SME) - Private and Academic Laboratories
Good Research and Laboratory Practice
Good Research and Laboratory Practice Small and Medium size Enterprises (SME) - Private and Academic Laboratories
Good Research and Laboratory Practice
Training RLM Consulting provides client specific courses on most aspects of EU
Training

RLM Consulting provides regulatory affairs support at all stages of the medicinal product development, from discovery research through preclinical and clinical testing, up to and beyond submission of the dossier required for marketing authorization.

Ideally regulatory guidance should be provided at the earliest possible stage of the product development, but we can help at any stage.

RLM Consulting provides strategic guidance (most appropriate regulatory scenario) as well as practical feedback. When appropriate we seek the advice of regulatory authorities (EMEA and national agencies

welcome_schema_la